SPARC Sun Pharma Advanced Research Company Ltd Product Launches Announcement 2025 - Vibozilimod Update Sun Pharma's partner announced that Vibozilimod (SCD-044) did not achieve its primary endpoints in Phase 2 trials for treating psoriasis and eczema. Further evaluation of the next steps will be undertaken..Find Corporate Announcements for Press Releases, AGM, Insider Trading & SAST, Results and Corporate Action for Sun Pharma Advanced Research Company Ltd